OSRX Inc.
Form 483 issued April 25, 2019 · Missoula, Montana
- Inspection
- Aug 28, 2018 – Apr 25, 2019
- Investigators
- Andrew K. Haack· Christopher R. Czajka
- Observations
- 1
- Pages
- 2
- FEI number
- 3014549846
In short: On April 25, 2019, FDA issued a Form 483 with 1 observation to OSRX Inc. in Missoula, Montana (FEI 3014549846) after an inspection that ran Aug 28, 2018 – Apr 25, 2019. The investigators were Andrew K. Haack and Christopher R. Czajka.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
Observation 1: scanned text, readable in the full document.
This inspection in context
Andrew K. Haack
12 documents · 2017–2023
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in Washington.
The firmOSRX Inc. history
All 6 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at OSRX Inc.?
FDA listed 1 observation on this Form 483. The opening words of each observation are shown on this page.
Who inspected OSRX Inc.?
Andrew K. Haack and Christopher R. Czajka are named on this Form 483, for the inspection of Aug 28, 2018 – Apr 25, 2019. Each investigator has a profile showing what they cite most.
When was OSRX Inc. inspected by FDA?
The inspection ran Aug 28, 2018 – Apr 25, 2019, and the Form 483 is dated April 25, 2019.
How do I get the full Form 483 for OSRX Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.